MDNews - Lower Hudson/Bronx

January 2017

Issue link: https://viewer.e-digitaledition.com/i/773802

Contents of this Issue

Navigation

Page 8 of 23

" The number of breast cancer treatments we can now provide or that are under investigation is amazing. From diagnosis to surgery, radiation therapy and systemic therapy, there has been much advancement in the ways we manage patients." CAROLYN WASSERHEIT, MD, DIRECTOR OF BREAST AND GYNECOLOGIC PROJECTS AND ASSOCIATE DIRECTOR OF THE BREAST DISEASE MANAGEMENT TEAM AT NEWYORK• PRESBYTERIAN LAWRENCE HOSPITAL NewYorkPresbyterian Medical Group Westchester medical oncologists Dr. Mills and Dr. Wasserheit consult with each other in the new NYP Lawrence Hospital Cancer Center. The two trained together and have worked with and known each other for more than 30 years. NYP Lawrence recently opened state-of-the-art operating rooms that allow surgeons to view real-time images and other data while they operate on patients. ENHANCED, HIGH-QUALITY COMPREHENSIVE CANCER SERVICES IN THE COMMUNITY NewYork-Presbyterian Lawrence Hospital's new Cancer Center, which opened Nov. 1, 2016, features an expanded outpatient Infusion Therapy Suite, as well as state-of-the-art technologies, such as a linear accelerator and PET/CT simulator. This equipment enables NYP Lawrence to o¥er on-site hypofractionated radiation therapy, image-guided radiation therapy and intensity-modulated radiation therapy — a huge advantage for breast cancer patients who otherwise would have to travel to other centers for treatments that are often needed daily for four to six weeks. The hospital's medical oncology services include consultations and second opinions, as well as chemotherapy, immunotherapy and hormone therapy. As with the approach to other cancers, physicians who manage breast cancer utilize targeted treatments that match the molecular signature on each patient's tumor when identified. "To perform genetic profiling of each patient's tumor, we send a sample of the tumor to the hospital's pathologists, who work in collaboration with CUMC's pathologists, to analyze and diagnose the cancer," says Carolyn Wasserheit, MD, Director of Breast and Gynecologic Projects and Associate Director of the Breast Disease Management Team at NYP Lawrence, Assistant Professor of Medicine at CUMC, and a medica l oncologist focusing on breast and gynecologic cancers with NYPMGW. "The genomic analysis of the tumor will create a profile to see if the cancer has any targetable mutations. If mutations are present, patients may be candidates for a clinical trial, or we may be able to prescribe a therapy to which their tumor has a better chance of responding." An example of such targeted, biologic treatments is cyclin- dependent kinase (CDK) 4/6 inhibitors. These oral therapies, whose side e¥ects are manageable, can be used in conjunction with other drugs and may be especially useful in patients with hormone- receptor-positive breast cancer. Because the NYPMGW Breast Disease Management Team has access to the latest cancer clinical trials at Columbia's NCI- Desig nated Herber t Ir ving Comprehensive Ca ncer Center, their eligible patients are referred there. The NYP Lawrence cancer care team facilitates the patients' participation in clinical trials at Columbia while coordinating their continued care at NYP Lawrence. PRIORITIZING SURVIVORSHIP AND RETURN TO WELLNESS The NYP Lawrence Hospital Cancer Center o¥ers a variety of sup- portive services to patients throughout their cancer journey, including palliative care, physical therapy and rehabilitation, and nutritional, psychosocial and spiritual counseling. Additionally, Cancer Center patients have access to the NYPMGW and ColumbiaDoctors networks, which consist of community-based primary care and specialist physicians throughout Westchester County. For example, Mona Kennedy, MD, an NYPMGW primary care physician with an additional certification in obesity medicine, is a member of the Breast Disease Management Team. Dr. Kennedy o¥ers nutritional consultations to address weight changes that can accompany cancer treatment and survivorship. 0 9 M D N E W S .C O M /// M D N E W S L O W E R H U D S O N / B R O N X ■ 2 017

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - January 2017